Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMSFOS: rTMS vs SSRI Effects on Gene Expression in Depression
NCT02042573Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Nov 2013
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoints: Leukocyte expression of the C-FOS gene at 8 weeks and Leukocyte expression of the DUSP1 gene at 8 weeks. Started Nov 2013; status: terminated.
Beyond the preview
Go deeper on NCT02042573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042573.